Allele-specific silencing of mutant huntingtin and ataxin-3 genes by targeting expanded CAG repeats in mRNAs

Jiaxin Hu, Masayuki Matsui, Keith T. Gagnon, Jacob C. Schwartz, Sylvie Gabillet, Khalil Arar, Jun Wu, Ilya Bezprozvanny, David R. Corey

Research output: Contribution to journalArticle

153 Citations (Scopus)

Abstract

Expanded trinucleotide repeats cause many neurological diseases. These include Machado-Joseph disease (MJD) and Huntington's disease (HD), which are caused by expanded CAG repeats within an allele of the ataxin-3 (ATXN3) and huntingtin (HTT) genes, respectively. Silencing expression of these genes is a promising therapeutic strategy, but indiscriminate inhibition of both the mutant and wild-type alleles may lead to toxicity, and allele-specific approaches have required polymorphisms that differ among individuals. We report that peptide nucleic acid and locked nucleic acid antisense oligomers that target CAG repeats can preferentially inhibit mutant ataxin-3 and HTT protein expression in cultured cells. Duplex RNAs were less selective than single-stranded oligomers. The activity of the peptide nucleic acids does not involve inhibition of transcription, and differences in mRNA secondary structure or the number of oligomer binding sites may be important. Antisense oligomers that discriminate between wild-type and mutant genes on the basis of repeat length may offer new options for developing treatments for MJD, HD and related hereditary diseases.

Original languageEnglish (US)
Pages (from-to)478-484
Number of pages7
JournalNature Biotechnology
Volume27
Issue number5
DOIs
StatePublished - May 2009

Fingerprint

Gene Targeting
Machado-Joseph Disease
Peptide Nucleic Acids
Genes
Alleles
Huntington Disease
Oligomers
Messenger RNA
Trinucleotide Repeat Expansion
Inborn Genetic Diseases
Gene Silencing
Mutant Proteins
Cultured Cells
Binding Sites
RNA
Trinucleotide Repeats
Gene Expression
Nucleic acids
Binding sites
Transcription

ASJC Scopus subject areas

  • Applied Microbiology and Biotechnology
  • Biotechnology
  • Molecular Medicine
  • Bioengineering
  • Biomedical Engineering

Cite this

Allele-specific silencing of mutant huntingtin and ataxin-3 genes by targeting expanded CAG repeats in mRNAs. / Hu, Jiaxin; Matsui, Masayuki; Gagnon, Keith T.; Schwartz, Jacob C.; Gabillet, Sylvie; Arar, Khalil; Wu, Jun; Bezprozvanny, Ilya; Corey, David R.

In: Nature Biotechnology, Vol. 27, No. 5, 05.2009, p. 478-484.

Research output: Contribution to journalArticle

Hu, Jiaxin ; Matsui, Masayuki ; Gagnon, Keith T. ; Schwartz, Jacob C. ; Gabillet, Sylvie ; Arar, Khalil ; Wu, Jun ; Bezprozvanny, Ilya ; Corey, David R. / Allele-specific silencing of mutant huntingtin and ataxin-3 genes by targeting expanded CAG repeats in mRNAs. In: Nature Biotechnology. 2009 ; Vol. 27, No. 5. pp. 478-484.
@article{3bfecda0e88240acaa1785cf8c561057,
title = "Allele-specific silencing of mutant huntingtin and ataxin-3 genes by targeting expanded CAG repeats in mRNAs",
abstract = "Expanded trinucleotide repeats cause many neurological diseases. These include Machado-Joseph disease (MJD) and Huntington's disease (HD), which are caused by expanded CAG repeats within an allele of the ataxin-3 (ATXN3) and huntingtin (HTT) genes, respectively. Silencing expression of these genes is a promising therapeutic strategy, but indiscriminate inhibition of both the mutant and wild-type alleles may lead to toxicity, and allele-specific approaches have required polymorphisms that differ among individuals. We report that peptide nucleic acid and locked nucleic acid antisense oligomers that target CAG repeats can preferentially inhibit mutant ataxin-3 and HTT protein expression in cultured cells. Duplex RNAs were less selective than single-stranded oligomers. The activity of the peptide nucleic acids does not involve inhibition of transcription, and differences in mRNA secondary structure or the number of oligomer binding sites may be important. Antisense oligomers that discriminate between wild-type and mutant genes on the basis of repeat length may offer new options for developing treatments for MJD, HD and related hereditary diseases.",
author = "Jiaxin Hu and Masayuki Matsui and Gagnon, {Keith T.} and Schwartz, {Jacob C.} and Sylvie Gabillet and Khalil Arar and Jun Wu and Ilya Bezprozvanny and Corey, {David R.}",
year = "2009",
month = "5",
doi = "10.1038/nbt.1539",
language = "English (US)",
volume = "27",
pages = "478--484",
journal = "Biotechnology",
issn = "0733-222X",
publisher = "Nature Publishing Group",
number = "5",

}

TY - JOUR

T1 - Allele-specific silencing of mutant huntingtin and ataxin-3 genes by targeting expanded CAG repeats in mRNAs

AU - Hu, Jiaxin

AU - Matsui, Masayuki

AU - Gagnon, Keith T.

AU - Schwartz, Jacob C.

AU - Gabillet, Sylvie

AU - Arar, Khalil

AU - Wu, Jun

AU - Bezprozvanny, Ilya

AU - Corey, David R.

PY - 2009/5

Y1 - 2009/5

N2 - Expanded trinucleotide repeats cause many neurological diseases. These include Machado-Joseph disease (MJD) and Huntington's disease (HD), which are caused by expanded CAG repeats within an allele of the ataxin-3 (ATXN3) and huntingtin (HTT) genes, respectively. Silencing expression of these genes is a promising therapeutic strategy, but indiscriminate inhibition of both the mutant and wild-type alleles may lead to toxicity, and allele-specific approaches have required polymorphisms that differ among individuals. We report that peptide nucleic acid and locked nucleic acid antisense oligomers that target CAG repeats can preferentially inhibit mutant ataxin-3 and HTT protein expression in cultured cells. Duplex RNAs were less selective than single-stranded oligomers. The activity of the peptide nucleic acids does not involve inhibition of transcription, and differences in mRNA secondary structure or the number of oligomer binding sites may be important. Antisense oligomers that discriminate between wild-type and mutant genes on the basis of repeat length may offer new options for developing treatments for MJD, HD and related hereditary diseases.

AB - Expanded trinucleotide repeats cause many neurological diseases. These include Machado-Joseph disease (MJD) and Huntington's disease (HD), which are caused by expanded CAG repeats within an allele of the ataxin-3 (ATXN3) and huntingtin (HTT) genes, respectively. Silencing expression of these genes is a promising therapeutic strategy, but indiscriminate inhibition of both the mutant and wild-type alleles may lead to toxicity, and allele-specific approaches have required polymorphisms that differ among individuals. We report that peptide nucleic acid and locked nucleic acid antisense oligomers that target CAG repeats can preferentially inhibit mutant ataxin-3 and HTT protein expression in cultured cells. Duplex RNAs were less selective than single-stranded oligomers. The activity of the peptide nucleic acids does not involve inhibition of transcription, and differences in mRNA secondary structure or the number of oligomer binding sites may be important. Antisense oligomers that discriminate between wild-type and mutant genes on the basis of repeat length may offer new options for developing treatments for MJD, HD and related hereditary diseases.

UR - http://www.scopus.com/inward/record.url?scp=66149181896&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=66149181896&partnerID=8YFLogxK

U2 - 10.1038/nbt.1539

DO - 10.1038/nbt.1539

M3 - Article

VL - 27

SP - 478

EP - 484

JO - Biotechnology

JF - Biotechnology

SN - 0733-222X

IS - 5

ER -